FSH-stimulated PTEN activity accounts for the lack of FSH mitogenic effect in prepubertal rat Sertoli cells

Molecular and Cellular Endocrinology

Volumn 315, Issue 1-2, 2010, Pages 271-276

  Dupont, Joëlle ^a,b,c   Musnier, Astrid ^a,b,c   Decourtye, Jérémy ^a,b,c   Boulo, Thomas ^a,b,c   Lécureuil, Charlotte ^d   Guillou, Hervé ^d   Valet, Sophie ^a,b,c   Fouchécourt, Sophie ^a,b,c   Pitetti, Jean Luc ^e   Nef, Serge ^e   Reiter, Eric ^a,b,c   Crépieux, Pascale ^a,b,c  

^a UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d BABRAHAM INSTITUTE   (United Kingdom)

^e UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Cell differentiation (rat testis); FSH; PTEN; Sertoli cells

Indexed keywords

FOLLITROPIN RELEASING FACTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME REGULATION; ENZYME SYNTHESIS; HORMONE ACTION; MALE; MITOGENESIS; NONHUMAN; PREPUBERTY; PRIORITY JOURNAL; RAT; SERTOLI CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELLS, CULTURED; FOLLICLE STIMULATING HORMONE; HUMANS; MALE; MITOSIS; PHOSPHATIDYLINOSITOLS; PTEN PHOSPHOHYDROLASE; PUBERTY; RATS; RATS, WISTAR; SERTOLI CELLS; SWINE; TRANSFERRIN;

EID: 72149123394     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.09.016     Document Type: Article

References (34)

1. Carnero A., Blanco-Aparicio C., Renner O., Link W., and Leal J.F. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr. Cancer Drug Targets 8 (2008) 187-198
2. Cederroth C.R., Schaad O., Descombes P., Chambon P., Vassalli J.D., and Nef S. Estrogen receptor alpha is a major contributor to estrogen-mediated fetal testis dysgenesis and cryptorchidism. Endocrinology 148 (2007) 5507-5519
3. Closset J., and Hennen G. Biopotency of highly purified porcine FSH and human LH on gonadal function. J. Endocrinol. 120 (1989) 89-96
4. Crépieux P., Marion S., Martinat N., Fafeur V., Vern Y.L., Kerboeuf D., Guillou F., and Reiter E. The ERK-dependent signalling is stage-specifically modulated by FSH, during primary Sertoli cell maturation. Oncogene 20 (2001) 4696-4709
5. Froment P., Bontoux M., Pisselet C., Monget P., and Dupont J. PTEN expression in ovine granulosa cells increases during terminal follicular growth. FEBS Lett. 579 (2005) 2376-2382
6. Guillou F., Martinat N., and Combarnous Y. Study of the superactivity of equine follicle-stimulating hormone in in vitro stimulation of rat Sertoli cells. Biochem. Biophys. Acta 887 (1986) 196-203
7. Guillou H., Lecureuil C., Anderson K.E., Suire S., Ferguson G.J., Ellson C.D., Gray A., Divecha N., Hawkins P.T., and Stephens L.R. Use of the GRP1 PH domain as a tool to measure the relative levels of PtdIns(3,4,5)P3 through a protein-lipid overlay approach. J. Lipid Res. 48 (2007) 726-732
8. Kara E., Crepieux P., Gauthier C., Martinat N., Piketty V., Guillou F., and Reiter E. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation. Mol. Endocrinol. 20 (2006) 3014-3026
9. Klarlund J.K., Guilherme A., Holik J.J., Virbasius J.V., Chawla A., and Czech M.P. Signaling by phosphoinositide-3,4,5-trisphosphate through proteins containing pleckstrin and Sec7 homology domains. Science 275 (1997) 1927-1930
10. Lackey J., Barnett J., Davidson L., Batty I.H., Leslie N.R., and Downes C.P. Loss of PTEN selectively desensitizes upstream IGF1 and insulin signaling. Oncogene 26 (2007) 7132-7142
11. Lecureuil C., Kara E., Guillou F., Monniaux D., and Crepieux P. Does FSH signaling have a gender?. Med. Sci. (Paris) 23 (2007) 75-80
12. Lécureuil C., Tesseraud S., Kara E., Martinat N., Sow A., Fontaine I., Gauthier C., Reiter E., Guillou F., and Crépieux P. Follicle-stimulating hormone activates p70 ribosomal protein S6 kinase by protein kinase A-mediated dephosphorylation of Thr 421/Ser 424 in primary Sertoli cells. Mol. Endocrinol. 19 (2005) 1812-1820
13. Meroni S.B., Riera M.F., Pellizzari E.H., and Cigorraga S.B. Regulation of rat Sertoli cell function by FSH: possible role of phosphatidylinositol 3-kinase/protein kinase B pathway. J. Endocrinol. 174 (2002) 195-204
14. Meroni S.B., Riera M.F., Pellizzari E.H., Galardo M.N., and Cigorraga S.B. FSH activates phosphatidylinositol 3-kinase/protein kinase B signaling pathway in 20-day-old Sertoli cells independently of IGF-I. J. Endocrinol. 180 (2004) 257-265
15. Moorehead R.A., Hojilla C.V., De Belle I., Wood G.A., Fata J.E., Adamson E.D., Watson K.L., Edwards D.R., and Khokha R. Insulin-like growth factor-II regulates PTEN expression in the mammary gland. J. Biol. Chem. 278 (2003) 50422-50427
16. Musnier, A., Heitzler, D., Boulo, T., Tesseraud, S., Durand G., Lécureuil, C., Guillou, H., Poupon, A., Reiter, E. Crépieux, P. Developmental regulation of p70 S6 kinase by a G protein-coupled receptor dynamically modelized in primary cells. Cellular and Molecular Life Sciences, 2009, doi:10.1007/s00018-009-0134-z [Epub ahead of print].
17. Nakamura K., Krupnick J.G., Benovic J.L., and Ascoli M. Signaling and phosphorylation-impaired mutants of the rat follitropin receptor reveal an activation- and phosphorylation-independent but arrestin-dependent pathway for internalization. J. Biol. Chem. 273 (1998) 24346-24354
18. Orth J.M. Proliferation of Sertoli cells in fetal and postnatal rats: a quantitative autoradiographic study. Anat. Rec. 203 (1982) 485-492
19. Reiter E., and Lefkowitz R.J. GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol. Metab. 17 (2006) 159-165
20. Stephens L., Eguinoa A., Corey S., Jackson T., and Hawkins P.T. Receptor stimulated accumulation of phosphatidylinositol (3,4,5)-trisphosphate by G-protein mediated pathways in human myeloid derived cells. EMBO J. 12 (1993) 2265-2273
21. Suh J.M., Song J.H., Kim D.W., Kim H., Chung H.K., Hwang J.H., Kim J.M., Hwang E.S., Chung J., Han J.H., Cho B.Y., Ro H.K., and Shong M. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland. J. Biol. Chem. 278 (2003) 21960-21971
22. Suire S., Fontaine I., and Guillou F. Follicle stimulating hormone (FSH) stimulates transferrin gene transcription in rat Sertoli cells: cis and trans-acting elements involved in FSH action via cyclic adenosine 3′,5′-monophosphate on the transferrin gene. Mol. Endocrinol. 9 (1995) 756-766
23. Suire S., Fontaine I., and Guillou F. Transferrin gene expression and secretion in rat sertoli cells. Mol. Reprod. Dev. 48 (1997) 168-175
24. Tamguney T., and Stokoe D. New insights into PTEN. J. Cell Sci. 120 (2007) 4071-4079
25. Tang X., Wang L., Proud C.G., and Downes C.P. Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase. Biochem. J. 374 (2003) 137-143
26. Torres J., and Pulido R. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J. Biol. Chem. 276 (2001) 993-998
27. Torres J., Rodriguez J., Myers M.P., Valiente M., Graves J.D., Tonks N.K., and Pulido R. Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3: implications for the control of protein stability and PTEN-protein interactions. J. Biol. Chem. 278 (2003) 30652-30660
28. Traenckner E.B., Wilk S., and Baeuerle P.A. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 13 (1994) 5433-5441
29. Troispoux C., Guillou F., Elalouf J.M., Firsov D., Iacovelli L., De Blasi A., Combarnous Y., and Reiter E. Involvement of G-protein coupled receptor kinases and arrestins in desensitization to FSH action. Mol. Endocrinol. 9 (1999) 1599-1614
30. Vazquez F., and Devreotes P. Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction. Cell Cycle 5 (2006) 1523-1527
31. Virolle T., Adamson E.D., Baron V., Birle D., Mercola D., Mustelin T., and de Belle I. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat. Cell Biol. 3 (2001) 1124-1128
32. Wang P., and DeFea K.A. Protease-activated receptor-2 simultaneously directs beta-arrestin-1-dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase. Biochemistry 45 (2006) 9374-9385
33. Wu Y., Karas M., Dupont J., Zhao H., Toyoshima Y., and Le Roith D. Multiple signaling pathways are involved in the regulation of IGF-I receptor inhibition of PTEN-enhanced apoptosis. Growth Horm. IGF Res. 14 (2004) 52-58
34. Xia D., Srinivas H., Ahn Y.H., Sethi G., Sheng X., Yung W.K., Xia Q., Chiao P.J., Kim H., Brown P.H., Wistuba I.I., Aggarwal B.B., and Kurie J.M. Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway. J. Biol. Chem. 282 (2007) 3507-3519